These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35871287)

  • 21. Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics.
    Handel AE; Chintawar S; Lalic T; Whiteley E; Vowles J; Giustacchini A; Argoud K; Sopp P; Nakanishi M; Bowden R; Cowley S; Newey S; Akerman C; Ponting CP; Cader MZ
    Hum Mol Genet; 2016 Mar; 25(5):989-1000. PubMed ID: 26740550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?
    Lopes C; Rego AC
    Mol Neurobiol; 2017 Apr; 54(3):1858-1873. PubMed ID: 26892627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy.
    Sougawa N; Miyagawa S; Fukushima S; Kawamura A; Yokoyama J; Ito E; Harada A; Okimoto K; Mochizuki-Oda N; Saito A; Sawa Y
    Sci Rep; 2018 Feb; 8(1):3726. PubMed ID: 29487310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells.
    Boraas LC; Guidry JB; Pineda ET; Ahsan T
    PLoS One; 2016; 11(1):e0145084. PubMed ID: 26771179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluripotent Stem Cell Heterogeneity.
    Hayashi Y; Ohnuma K; Furue MK
    Adv Exp Med Biol; 2019; 1123():71-94. PubMed ID: 31016596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
    Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
    Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early prediction of the differentiation potential during the formation of human iPSC-derived embryoid bodies.
    Guo NN; Liu LP; Zhang YX; Cai YT; Guo Y; Zheng YW; Li YM
    Biochem Biophys Res Commun; 2019 Aug; 516(3):673-679. PubMed ID: 31248595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.
    Baghbaderani BA; Syama A; Sivapatham R; Pei Y; Mukherjee O; Fellner T; Zeng X; Rao MS
    Stem Cell Rev Rep; 2016 Aug; 12(4):394-420. PubMed ID: 27283945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large structural variants in KOLF2.1J are unlikely to compromise neurological disease modelling.
    Ryan M; McDonough JA; Ward ME; Cookson MR; Skarnes WC; Merkle FT
    bioRxiv; 2024 Jan; ():. PubMed ID: 38352495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
    Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing PCDH19 in human induced pluripotent stem cells (iPSCs) and iPSC-derived developing neurons: emerging role of a protein involved in controlling polarity during neurogenesis.
    Compagnucci C; Petrini S; Higuraschi N; Trivisano M; Specchio N; Hirose S; Bertini E; Terracciano A
    Oncotarget; 2015 Sep; 6(29):26804-13. PubMed ID: 26450854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
    Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
    Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and Proteome Profiling of PBMC-Originated, iPSC-Derived Corneal Endothelial Cells.
    Ali M; Khan SY; Vasanth S; Ahmed MR; Chen R; Na CH; Thomson JJ; Qiu C; Gottsch JD; Riazuddin SA
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2437-2444. PubMed ID: 29847650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA Profiling During Neural Differentiation of Induced Pluripotent Stem Cells.
    Kulcenty K; Wroblewska JP; Rucinski M; Kozlowska E; Jopek K; Suchorska WM
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells.
    Yamashita A; Liu S; Woltjen K; Thomas B; Meng G; Hotta A; Takahashi K; Ellis J; Yamanaka S; Rancourt DE
    Sci Rep; 2013; 3():1978. PubMed ID: 23760219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
    Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
    Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.